FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Howard Birnbaum

Research Profile

Geographic Areas

United States

Concepts & Ideas

Activities & Behaviors

Procedures

Disorders

Organizations

Health Benefit Plans, Employee

Co-author Network

Publications

TOP 3
Scott J Johnson; Anna Kaltenboeck; Howard G Birnbaum; Melissa D Diener; Andrew D Siderowf
An economic model of Parkinson's disease: implications for slowing progression in the United States.
Noam Y Kirson; Sumati Rao; Robert S Wei; Howard G Birnbaum; Evan Kantor; Mary A Cifaldi
Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritis.
Howard G Birnbaum; Crystal Pike; Tracy Waldman; Ritesh Banerjee; Mary A Cifaldi
Changes in utilization and costs for patients with rheumatoid arthritis, 1997 to 2006.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Howard Birnbaum (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Scott J Johnson; Anna Kaltenboeck; Howard G Birnbaum; Melissa D Diener; Andrew D Siderowf
An economic model of Parkinson's disease: implications for slowing progression in the United States.
Movement disorders : official journal of the Movement Disorder Society 2013;28(3):319-26.
2013: Noam Y Kirson; Sumati Rao; Robert S Wei; Howard G Birnbaum; Evan Kantor; Mary A Cifaldi
Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritis.
Journal of medical economics 2013;16(4):479-89.
2012: Howard G Birnbaum; Crystal Pike; Tracy Waldman; Ritesh Banerjee; Mary A Cifaldi
Changes in utilization and costs for patients with rheumatoid arthritis, 1997 to 2006.
PharmacoEconomics 2012;30(4):323-36.
2012: Crystal T Pike; Gerhardt M Pohl; Howard G Birnbaum; Catherine E Muehlenbein; Ronald B Natale
Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer.
Chemotherapy research and practice 2012;2012():913848.
2011: C T Pike; M Schiller; E Swallow; Howard G Birnbaum; R T Burge; E T Edgell
Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2011;22(10):2611-21.
2011: Jasmina I Ivanova; Catherine Bienfait-Beuzon; Howard G Birnbaum; Cristina Connolly; Srinivas Emani; Michael Sheehy
Physicians' decisions to prescribe antidepressant therapy in older patients with depression in a US managed care plan.
Drugs & aging 2011;28(1):51-62.
2011: C Pike; Howard G Birnbaum; M Schiller; E Swallow; R T Burge; E T Edgell
Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2011;22(1):47-56.
2010: Nathaniel P Katz; Howard G Birnbaum; Adam Castor
Volume of prescription opioids used nonmedically in the United States.
Journal of pain & palliative care pharmacotherapy 2010;24(2):141-4.
2010: Ronald C Kessler; Howard G Birnbaum; Victoria Shahly; Evelyn J Bromet; Irving Hwang; Kelly McLaughlin; Nancy Sampson; Laura Helena Andrade; Giovanni de Girolamo; Koen Demyttenaere; Josep Maria Haro; Aimee N Karam; Stanislav Kostyuchenko; Viviane Kovess; Carmen Lara; Daphna Levinson; Herbert Matschinger; Yoshibumi Nakane; Mark Oakley Browne; Johan Ormel; José Posada-Villa; Rajesh Sagar; Dan Stein
Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative.
Depression and anxiety 2010;27(4):351-64.
2010: Howard G Birnbaum; Rym Ben-Hamadi; David Kelley; Matthew Hsieh; Brian Seal; Evan Kantor; Pierre Y Cremieux; Paul E Greenberg
Assessing the relationship between compliance with antidepressant therapy and employer costs among employees in the United States.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2010;52(2):115-24.
2010: Ronald C Kessler; Howard G Birnbaum; E Bromet; I Hwang; N Sampson; V Shahly
Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R).
Psychological medicine 2010;40(2):225-37.
2010: Howard G Birnbaum; Paul E Greenberg
Introducing perspectives on comparative effectiveness research.
PharmacoEconomics 2010;28(10):787-8.
2010: Crystal Pike; Howard G Birnbaum; Matt Schiller; Hari Sharma; Russel Burge; Eric T Edgell
Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.
PharmacoEconomics 2010;28(5):395-409.
2010: Howard G Birnbaum; Crystal Pike; Rebecca Kaufman; Yohanne Kidolezi; Maryna Marynchenko; Mary A Cifaldi
Societal cost of rheumatoid arthritis patients in the US.
Current medical research and opinion 2010;26(1):77-90.
2010: Lauren J Lee; Andrew P Yu; Scott J Johnson; Howard G Birnbaum; Pavel Atanasov; DP Buesching; Jeffrey A Jackson; Jaime A Davidson
Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: a retrospective database analysis.
Diabetes research and clinical practice 2010;87(1):108-16.
2010: Howard G Birnbaum; Ronald C Kessler; David Kelley; Rym Ben-Hamadi; Vijay N Joish; Paul E Greenberg
Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance.
Depression and anxiety 2010;27(1):78-89.
2009: Leigh Ann White; Rebecca L Robinson; Andrew P Yu; Anna Kaltenboeck; Seth Samuels; David Mallett; Howard G Birnbaum
Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia.
The journal of pain : official journal of the American Pain Society 2009;10(9):976-83.
2009: Andrew P Yu; Rym Ben-Hamadi; Howard G Birnbaum; Pavel Atanasov; Michael D Stensland; Glenn Philips
Comparing the treatment patterns of patients with schizophrenia treated with olanzapine and quetiapine in the Pennsylvania Medicaid population.
Current medical research and opinion 2009;25(3):755-64.
2009: Howard G Birnbaum; J I Ivanova; A P Yu; M Hsieh; B Seal; S Emani; R Rosiello; G L Colice
Asthma severity categorization using a claims-based algorithm or pulmonary function testing.
The Journal of asthma : official journal of the Association for the Care of Asthma 2009;46(1):67-72.
2009: Howard G Birnbaum; Rym Ben-Hamadi; Paul E Greenberg; Matthew Hsieh; Jackson Tang; Camille Reygrobellet
Determinants of direct cost differences among US employees with major depressive disorders using antidepressants.
PharmacoEconomics 2009;27(6):507-17.
2009: Alan G White; Howard G Birnbaum; Dov B Rothman; Nathaniel Katz
Development of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extraction.
Applied health economics and health policy 2009;7(1):61-70.
2008: Ronald Kessler; Leigh Ann White; Howard G Birnbaum; Ying Qiu; Yohanne Kidolezi; David Mallett; Ralph Swindle
Comparative and interactive effects of depression relative to other health problems on work performance in the workforce of a large employer.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2008;50(7):809-16.
2008: Gene L Colice; Andrew P Yu; Jasmina I Ivanova; Matthew Hsieh; Howard G Birnbaum; Maureen J Lage; Corrine Brewster
Costs and resource use of mild persistent asthma patients initiated on controller therapy.
The Journal of asthma : official journal of the Association for the Care of Asthma 2008;45(4):293-9.
2008: Leigh Ann White; Howard G Birnbaum; Anna Kaltenboeck; Jackson Tang; David Mallett; Rebecca L Robinson
Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2008;50(1):13-24.
2007: Eric S Meadows; Matthew Rousculp; Alicia C Sasser; Howard G Birnbaum; Erick Moyneur; David Mallet; Joseph A Johnston
Actual versus predicted first-year utilization patterns of teriparatide in patients with employer-sponsored health insurance.
Current medical research and opinion 2007;23(12):3215-22.
2007: Eric Q Wu; Howard G Birnbaum; Huabin F Zhang; Jasmina I Ivanova; Elaine Yang; David Mallet
Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.
Journal of managed care pharmacy : JMCP 2007;13(7):561-9.
2007: Andrew P Yu; Eric Q Wu; Howard G Birnbaum; Srinivas Emani; Madeleine Fay; Gerhardt Pohl; Matthew Wintle; Elaine Yang; Andalan Oglesby
Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.
Current medical research and opinion 2007;23(9):2157-69.
2007: Eric Wu; Lei Chen; Howard G Birnbaum; Elaine Yang; Mary A Cifaldi
Cost of care for patients with rheumatoid arthritis receiving TNF-antagonist therapy using claims data.
Current medical research and opinion 2007;23(8):1749-59.
2007: Gene L Colice; Eric Q Wu; Howard G Birnbaum; Maham Daher; B Marynchenko Maryna
Use of inhaled corticosteroids and healthcare costs in mild persistent asthma.
The Journal of asthma : official journal of the Association for the Care of Asthma 2007;44(6):479-83.
2007: Nathaniel P Katz; Edgar H Adams; James C Benneyan; Howard G Birnbaum; Simon H Budman; Ronald W Buzzeo; Daniel B Carr; Theodore J Cicero; Douglas Gourlay; James A Inciardi; David E Joranson; James Kesslick; Stephen D Lande
Foundations of opioid risk management.
The Clinical journal of pain 2007;23(2):103-18.
2007: Lizheng Shi; Eric Q Wu; Meredith Hodges; Andrew Yu; Howard G Birnbaum
Retrospective economic and outcomes analyses using non-US databases: a review.
PharmacoEconomics 2007;25(7):563-76.
2007: Ronald C Kessler; Hagop S Akiskal; Minnie Ames; Howard G Birnbaum; Paul E Greenberg; Robert M A Hirschfeld; Philip S Wang
Considering the costs of bipolar depression.
Behavioral healthcare 2007;27(1):45-7.
2006: Eric Q Wu; Lizheng Shi; Howard G Birnbaum; Teresa Hudson; Ronald Kessler
Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach.
Psychological medicine 2006;36(11):1535-40.
2006: Katherine E Hartmann; Howard G Birnbaum; Rym Ben-Hamadi; Eric Q Wu; Max H Farrell; James Spalding; Paul Stang
Annual costs associated with diagnosis of uterine leiomyomata.
Obstetrics and gynecology 2006;108(4):930-7.
2006: Howard G Birnbaum; Alan G White; Jennifer L Reynolds; Paul E Greenberg; Mingliang Zhang; Sue Vallow; Jeff Schein; Nathaniel P Katz
Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.
The Clinical journal of pain 2006;22(8):667-76.
2006: Eric Q Wu; Howard G Birnbaum; M Cifaldi; Y Kang; David Mallet; Gene L Colice
Development of a COPD severity score.
Current medical research and opinion 2006;22(9):1679-87.
2006: Ronald C Kessler; Hagop S Akiskal; Minnie Ames; Howard G Birnbaum; Paul Greenberg; Robert M A Hirschfeld; Robert Jin; Kathleen Ries Merikangas; Gregory E Simon; Philip S Wang
Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers.
The American journal of psychiatry 2006;163(9):1561-8.
2006: Gene L Colice; Eric Q Wu; Howard G Birnbaum; Maham Daher; Maryna Marynchenko; S Varghese
Healthcare and workloss costs associated with patients with persistent asthma in a privately insured population.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2006;48(8):794-802.
2006: Eric Q Wu; Howard G Birnbaum; Milena N Mareva; T Kim Le; Rebecca L Robinson; Amy Rosen; Steve Gelwicks
Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
The journal of pain : official journal of the American Pain Society 2006;7(6):399-407.
2006: Eric Q Wu; Howard G Birnbaum; Yoon Jun Kang; Andrew Parece; David Mallett; Haya Taitel; Robert J Evans
A retrospective claims database analysis to assess patterns of interstitial cystitis diagnosis.
Current medical research and opinion 2006;22(3):495-500.
2006: Eric Q Wu; Howard G Birnbaum; Milena N Mareva; Andrew Parece; Zihong Huang; David Mallett; Haya Taitel
Interstitial Cystitis: Cost, treatment and co-morbidities in an employed population.
PharmacoEconomics 2006;24(1):55-65.
2005: Ronald C Kessler; Howard G Birnbaum; Olga Demler; Ian R H Falloon; Elizabeth Gagnon; Margaret Guyer; Mary J Howes; Kenneth S Kendler; Lizheng Shi; Ellen Walters; Eric Q Wu
The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R).
Biological psychiatry 2005;58(8):668-76.
2005: Eric Q Wu; Howard G Birnbaum; Milena N Mareva; Edward Tuttle; Adam R Castor; Warren Jackman; Jeremy Ruskin
Economic burden and co-morbidities of atrial fibrillation in a privately insured population.
Current medical research and opinion 2005;21(10):1693-9.
2005: Eric Q Wu; Howard G Birnbaum; Lizheng Shi; Daniel E Ball; Ronald C Kessler; Matthew Moulis; Jyoti Aggarwal
The economic burden of schizophrenia in the United States in 2002.
The Journal of clinical psychiatry 2005;66(9):1122-9.
2005: Alan G White; Howard G Birnbaum; Milena N Mareva; Aaron E Henckler; Patricia Grossman; David Mallett
Economic burden of illness for employees with painful conditions.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2005;47(9):884-92.
2005: Alicia C Sasser; Maida Taylor; Howard G Birnbaum; Michael J Schoenfeld; Emily F Oster; Matthew Rousculp
Assessing the economic impact of chronic conditions in postmenopausal women.
Expert opinion on pharmacotherapy 2005;6(11):1803-14.
2005: Alan G White; Howard G Birnbaum; Milena N Mareva; Maham Daher; Sue Vallow; Jeff Schein; Nathaniel Katz
Direct costs of opioid abuse in an insured population in the United States.
Journal of managed care pharmacy : JMCP 2005;11(6):469-79.
2005: Ronald C Kessler; Lenard Adler; Minnie Ames; Russell Barkley; Howard G Birnbaum; Paul Greenberg; Joseph A Johnston; Thomas Spencer; T Bedirhan Ustün
The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2005;47(6):565-72.
2005: Alicia C Sasser; Matthew Rousculp; Howard G Birnbaum; Emily F Oster; Edward Lufkin; David Mallet
Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population.
Women's health issues : official publication of the Jacobs Institute of Women's Health 2005;15(3):97-108.
2005: Eric Q Wu; Howard G Birnbaum; Maryna Marynchenko; Milena N Mareva; Todd Williamson; David Mallett
Employees with overactive bladder: work loss burden.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2005;47(5):439-46.
2005: Paul E Greenberg; Howard G Birnbaum
The economic burden of depression in the US: societal and patient perspectives.
Expert opinion on pharmacotherapy 2005;6(3):369-76.
2005: Howard G Birnbaum; Ronald C Kessler; Sarah W Lowe; Kristina Secnik; Paul E Greenberg; Stephanie A Leong; Andrine R Swensen
Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
Current medical research and opinion 2005;21(2):195-206.
2004: Andrine R Swensen; Howard G Birnbaum; Rym Ben-Hamadi; Paul Greenberg; Pierre-Yves Cremieux; Kristina Secnik
Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2004;35(4):346.e1-9.
2004: Rebecca L Robinson; Howard G Birnbaum; Melissa A Morley; Tamar Sisitsky; Paul E Greenberg; Frederick Wolfe
Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently.
The Journal of rheumatology 2004;31(8):1621-9.
2004: Gene L Colice; Melissa A Morley; Carl V Asche; Howard G Birnbaum
Treatment costs of community-acquired pneumonia in an employed population.
Chest 2004;125(6):2140-5.
2004: Paul Greenberg; Patricia K Corey-Lisle; Howard G Birnbaum; Maryna Marynchenko; Ami J Claxton
Economic implications of treatment-resistant depression among employees.
PharmacoEconomics 2004;22(6):363-73.
2004: Howard G Birnbaum; Stephanie A Leong; Emily F Oster; Kraig S Kinchen; Peter Sun
Cost of stress urinary incontinence: a claims data analysis.
PharmacoEconomics 2004;22(2):95-105.
2003: Paul E Greenberg; Ronald C Kessler; Howard G Birnbaum; Stephanie A Leong; Sarah W Lowe; Patricia A Berglund; Patricia K Corey-Lisle
The economic burden of depression in the United States: how did it change between 1990 and 2000?
The Journal of clinical psychiatry 2003;64(12):1465-75.
2003: Andrine R Swensen; Howard G Birnbaum; Kristina Secnik; Maryna Marynchenko; Paul Greenberg; Ami J Claxton
Attention-deficit/hyperactivity disorder: increased costs for patients and their families.
Journal of the American Academy of Child and Adolescent Psychiatry 2003;42(12):1415-23.
2003: Howard G Birnbaum; Stephanie Leong; Aayush Kabra
Lifetime medical costs for women: cardiovascular disease, diabetes, and stress urinary incontinence.
Women's health issues : official publication of the Jacobs Institute of Women's Health 2003;13(6):204-13.
2003: Howard G Birnbaum; Lizheng Shi; Ellison Dial; Emily F Oster; Paul E Greenberg; David Mallett
Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis.
The Journal of clinical psychiatry 2003;64(10):1201-9.
2003: Laurence Baker; Howard G Birnbaum; Jeffrey Geppert; David Mishol; Erick Moyneur
The relationship between technology availability and health care spending.
Health affairs (Project Hope) 2003;Suppl Web Exclusives():W3-537-51.
2003: Rebecca L Robinson; Howard G Birnbaum; Melissa A Morley; Tamar Sisitsky; Paul E Greenberg; Ami J Claxton
Economic cost and epidemiological characteristics of patients with fibromyalgia claims.
The Journal of rheumatology 2003;30(6):1318-25.
2003: Stephanie A Leong; Victoria Barghout; Howard G Birnbaum; Crystal E Thibeault; Rym Ben-Hamadi; Feride Frech; Joshua J Ofman
The economic consequences of irritable bowel syndrome: a US employer perspective.
Archives of internal medicine 2003;163(8):929-35.
2003: Howard G Birnbaum; Stephanie A Leong; Paul E Greenberg
The economics of women and depression: an employer's perspective.
Journal of affective disorders 2003;74(1):15-22.
2003: Patricia K Corey-Lisle; Howard G Birnbaum; Paul Greenberg; Maryna Marynchenko; Sanjay Dube
Economic impact of olanzapine plus fluoxetine combination therapy among patients treated for depression: a pilot study.
Psychopharmacology bulletin 2003;37(3):90-8.
2003: Howard G Birnbaum; Melissa Morley; Stephanie Leong; Paul Greenberg; Gene L Colice
Lower respiratory tract infections: impact on the workplace.
PharmacoEconomics 2003;21(10):749-59.
2003: Paul E Greenberg; Stephanie A Leong; Howard G Birnbaum; Rebecca L Robinson
The economic burden of depression with painful symptoms.
The Journal of clinical psychiatry 2003;64 Suppl 7():17-23.
2002: Patricia K Corey-Lisle; Howard G Birnbaum; Paul E Greenberg; Maryna Marynchenko; Ami J Claxton
Identification of a claims data "signature" and economic consequences for treatment-resistant depression.
The Journal of clinical psychiatry 2002;63(8):717-26.
2002: Howard G Birnbaum; Melissa A Morley; Paul E Greenberg; Gene L Colice
Economic burden of respiratory infections in an employed population.
Chest 2002;122(2):603-11.
2002: Howard G Birnbaum; William E Berger; Paul E Greenberg; Michael Holland; Rebecca Auerbach; Kelly M Atkins; Lee A Wanke
Direct and indirect costs of asthma to an employer.
The Journal of allergy and clinical immunology 2002;109(2):264-70.
2002: Scott Ramsey; Kent H Summers; Stephanie A Leong; Howard G Birnbaum; Jason E Kemner; Paul Greenberg
Productivity and medical costs of diabetes in a large employer population.
Diabetes care 2002;25(1):23-9.
2001: Howard G Birnbaum; Melissa A Morley; Paul E Greenberg; M Cifaldi; Gene L Colice
Economic burden of pneumonia in an employed population.
Archives of internal medicine 2001;161(22):2725-31.
2001: Paul E Greenberg; Stephanie A Leong; Howard G Birnbaum
Assessing the economic impact of psychiatric disorders: where to begin?
Expert opinion on pharmacotherapy 2001;2(4):641-52.
2001: Paul E Greenberg; Howard G Birnbaum; R C Kessler; M Morgan; P Stang
Impact of illness and its treatment on workplace costs: regulatory and measurement issues.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2001;43(1):56-63.
2001: Gregory E Simon; Catherine Barber; Howard G Birnbaum; Richard G Frank; Paul E Greenberg; R M Rose; P S Wang; Ronald C Kessler
Depression and work productivity: the comparative costs of treatment versus nontreatment.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2001;43(1):2-9.
2000: A Barnett; Howard G Birnbaum; P Y Cremieux; A Mark Fendrick; M Slavin
The costs of cancer to a major employer in the United States: a case-control analysis.
The American journal of managed care 2000;6(11):1243-51.
2000: L N Venditti; A Arcelus; Howard G Birnbaum; P Greenberg; Charles Barr; C Rowland; T Williamson
The impact of antidepressant use on social functioning: reboxetine versus fluoxetine.
International clinical psychopharmacology 2000;15(5):279-89.
2000: Howard G Birnbaum; M Barton; Paul E Greenberg; Tamar Sisitsky; R Auerbach; Lee A Wanke; M C Buatti
Direct and indirect costs of rheumatoid arthritis to an employer.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2000;42(6):588-96.
2000: Jacques LeLorier; Sylvie Perreault; Howard G Birnbaum; P Greenberg; Odile Sheehy
Savings in direct medical costs from the use of tobramycin solution for inhalation in patients with cystic fibrosis.
Clinical therapeutics 2000;22(1):140-51.
1999: Paul E Greenberg; A Arcelus; Howard G Birnbaum; Pierre-Yves Cremieux; Jacques LeLorier; P Ouellette; M B Slavin
Pharmacoeconomics and health policy. Current applications and prospects for the future.
PharmacoEconomics 1999;16(5 Pt 1):425-32.
1999: Ronald C Kessler; Catherine Barber; Howard G Birnbaum; Richard G Frank; Paul E Greenberg; R M Rose; Gregory E Simon; P Wang
Depression in the workplace: effects on short-term disability.
Health affairs (Project Hope) 1999;18(5):163-71.
1999: Howard G Birnbaum; Pierre-Yves Cremieux; Paul E Greenberg; Jacques LeLorier; J A Ostrander; L Venditti
Using healthcare claims data for outcomes research and pharmacoeconomic analyses.
PharmacoEconomics 1999;16(1):1-8.